Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:45:20.932Z.
Calculation as of: 2026-10-06T13:45:20.932Z.
Quote observation: 2026-10-06T13:43:53.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bd475241593d5c58f7737f650220a879a7f67ee05652ed27eb0102460b642cb0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Acrivon Therapeutics, Inc. Common Stock
Market Cap
$87.10M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$85.53M
Free Cash Flow Yield
N/A
TTM Avg
0.15%
3Y Avg
0.15%
5Y Avg
0.15%
Market Cap
$84.44M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$87.11M
Free Cash Flow Yield
24.88%
TTM Avg
19.27%
3Y Avg
25.95%
5Y Avg
22.72%
Market Cap
$81.54M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$88.63M
Free Cash Flow Yield
N/A
TTM Avg
5.92%
3Y Avg
6.70%
5Y Avg
6.29%
Market Cap
$88.84M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. Common Stock (ACRV) | $87.10M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $85.53M | N/A | 0.15% | 0.15% | 0.15% |
| Humacyte, Inc. (HUMA)vs › | $84.52M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.44M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $87.11M | 24.88% | 19.27% | 25.95% | 22.72% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $81.54M | N/A | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $81.80M | N/A | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | N/A | 5.92% | 6.70% | 6.29% |
| Conexeu Sciences Inc. (CNXU)vs › | $88.84M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 4.73% | 2.62% | 2.45% | 2.45% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
